Clinical uses of intravenous immunoglobulin

被引:248
作者
Jolles, S
Sewell, WAC
Misbah, SA
机构
[1] Royal Free Hosp, Dept Clin Immunol, London NW3 2QG, England
[2] Natl Inst Med Res, London NW7 1AA, England
[3] Churchill Hosp, Dept Clin Immunol, Oxford OX3 7LJ, England
关键词
Fc receptor; Guillain-Barre syndrome; immune thrombocytopenia; intravenous immunoglobulin; Kawasaki disease;
D O I
10.1111/j.1365-2249.2005.02834.X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1 / 11
页数:11
相关论文
共 124 条
[1]   ENZYME-LINKED IMMUNOSORBENT-ASSAY (ELISA) FOR HUMAN-TUMOR NECROSIS FACTOR (HTNF) [J].
ABE, Y ;
MIYAKE, M ;
SAGAWA, T ;
KIMURA, S .
CLINICA CHIMICA ACTA, 1988, 176 (02) :213-217
[2]   ANTI-CYTOKINE NATURE OF NATURAL HUMAN-IMMUNOGLOBULIN - ONE POSSIBLE MECHANISM OF THE CLINICAL EFFECT OF INTRAVENOUS IMMUNOGLOBULIN THERAPY [J].
ABE, Y ;
HORIUCHI, A ;
MIYAKE, M ;
KIMURA, S .
IMMUNOLOGICAL REVIEWS, 1994, 139 :5-19
[3]   Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia [J].
Aghamohammadi, A ;
Moin, M ;
Farhoudi, A ;
Rezaei, N ;
Pourpak, Z ;
Movahedi, M ;
Gharagozlou, M ;
Nabavi, M ;
Shahrokhi, A .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2004, 40 (02) :113-118
[4]   Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy [J].
Ahmed, AR .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (08) :1019-1032
[5]   Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis [J].
Aktas, O ;
Waiczies, S ;
Grieger, U ;
Wendling, U ;
Zschenderlein, R ;
Zipp, F .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 114 (1-2) :160-167
[6]   Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro [J].
Alder, LBA ;
Morgan, LA ;
Spickett, GP .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 44 (06) :585-591
[7]   The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile [J].
Amagai, M ;
Tsunoda, K ;
Zillikens, D ;
Nagai, T ;
Nishikawa, T .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (02) :167-170
[8]   Increased risk of adverse events when changing intravenous immunoglobulin preparations [J].
Ameratunga, R ;
Sinclair, J ;
Kolbe, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (01) :111-113
[9]   USE OF INTRAVENOUS GAMMA-GLOBULIN IN ANTIBODY IMMUNODEFICIENCY - RESULTS OF A MULTI-CENTER CONTROLLED TRIAL [J].
AMMANN, AJ ;
ASHMAN, RF ;
BUCKLEY, RH ;
HARDIE, WR ;
KRANTMANN, HJ ;
NELSON, J ;
OCHS, H ;
STIEHM, ER ;
TILLER, T ;
WARA, DW ;
WEDGWOOD, R .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 22 (01) :60-67
[10]   POOLED HUMAN-IGG MODULATES CYTOKINE PRODUCTION IN LYMPHOCYTES AND MONOCYTES [J].
ANDERSSON, U ;
BJORK, L ;
SKANSENSAPHIR, U ;
ANDERSSON, J .
IMMUNOLOGICAL REVIEWS, 1994, 139 :21-42